| Trial ID: | L3216 |
| Source ID: | NCT00670722
|
| Associated Drug: |
Insulin Aspart
|
| Title: |
Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin aspart|DRUG: insulin detemir|DRUG: biphasic insulin aspart 30
|
| Outcome Measures: |
Primary: HbA1c after switch from human insulin to modern insulin treatment, After 24 weeks | Secondary: Percentage of subjects to reach HbA1c below 7.0% and = 6.5% at approximately 12 weeks and 24 weeks of treatment, After 12 and 24 weeks|Postprandial glycaemic control as measured by PPG, After 12 and 24 weeks|Glucose variability as measured by FPG, After 12 and 24 weeks|Insulin dose and number of injections, After 12 and 24 weeks|Body weight, After 12 and 24 weeks|Number of hypoglycaemic events, During treatment|Number of adverse drug reactions (ADR), After 12 and 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
6500
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-01
|
| Completion Date: |
2009-12
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-28
|
| Locations: |
Novo Nordisk Investigational Site, Prague, 16000, Czech Republic
|
| URL: |
https://clinicaltrials.gov/show/NCT00670722
|
